HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Market In Brief

This article was originally published in The Rose Sheet

Executive Summary

Galderma: New Cetaphil UVA/UVB Defense SPF 50 "is fragrance-free, non-irritating and non-comedogenic, so it won't clog pores, making it a suitable choice for those with acne, rosacea or melasma and other skin-related conditions where a hydrating formula with SPF protection is recommended," cosmeceutical firm says. Product, which flaunts the Skin Cancer Foundation Seal of Recommendation, is formulated with an "optimum blend" of four UV filters and micronized titanium dioxide for broad-spectrum protection. It retails for $13.99 for 1.7 oz. at major retail, grocery and drug stores nationwide, according to Galderma, which was launched in 1981 as a joint venture between Nestle and L'Oreal

You may also be interested in...



Cetaphil Targets Restoraderm To Consumers With Eczema, Atopic Dermatitis

Galderma's Cetaphil skin-care brand looks to reach new demographics with its recent introduction of a "disease-specific" product line

Cetaphil Targets Restoraderm To Consumers With Eczema, Atopic Dermatitis

Galderma's Cetaphil skin-care brand looks to reach new demographics with its recent introduction of a "disease-specific" product line

JAAD Lit Review Explores Data Behind Cosmeceutical Vitamin Claims

Though a strong body of evidence supports the notion that topical vitamins can help prevent and treat photo-aging of skin, a literature review published in the Journal of the American Academy of Dermatology warns dermatologists of some gaps that exist in the data

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015981

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel